|
|
||||||||


* Institut National de la Santé et de la Recherche Médicale Unité 431, IFR 56, University of Montpellier II, Montpellier, France; and
Sanofi Recherche, Montpellier, France
Brucella spp. are intramacrophage pathogens that induce chronic infections in a wide range of mammals, including domestic animals and humans. Therefore, the macrophage response to infection has important consequences for both the survival of phagocytosed bacteria and the further development of host immunity. However, very little is known about the macrophage cell signaling pathways initiated upon infection and the virulence strategy that Brucella use to counteract these responses and secure their survival. In a previous study, we have shown that macrophages activated by SR141716A, a ligand of the cannabinoid receptor CB1, acquired the capacity to control Brucella and observed that the CB1 receptor-triggering engages the microbicidal activity of phagocytes. To analyze the perturbation of cell signaling pathway during macrophage infection by Brucella, we hypothesized that SR141716A provides cell signaling that interferes with the bacterial message leading to inhibition of macrophage functions. As CB1 receptor belongs to the family of G protein-linked receptors, we explored the cAMP signaling pathway. In this study, we show that the CB1 ligand inhibited the bacteria-induced cell signaling. Taking advantage of this result, we then demonstrated that Brucella infection elicited a rapid activation of the cAMP/protein kinase A pathway. This activation resulted in a prolonged phosphorylation of the transcription factor CREB. We finally demonstrate that the activation of the cAMP/protein kinase A pathway is crucial for the survival and establishment of Brucella within macrophages. For the first time in phagocytes, we thus characterized a primordial virulence strategy of Brucella involving the host signaling pathway, a novel point of immune intervention of this virulent pathogen.
This article has been cited by other articles:
![]() |
E. Billard, J. Dornand, and A. Gross Interaction of Brucella suis and Brucella abortus Rough Strains with Human Dendritic Cells Infect. Immun., December 1, 2007; 75(12): 5916 - 5923. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bai, M. A. Gazdik, D. D. Schaak, and K. A. McDonough The Mycobacterium bovis BCG Cyclic AMP Receptor-Like Protein Is a Functional DNA Binding Protein In Vitro and In Vivo, but Its Activity Differs from That of Its M. tuberculosis Ortholog, Rv3676 Infect. Immun., November 1, 2007; 75(11): 5509 - 5517. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Billard, J. Dornand, and A. Gross Brucella suis Prevents Human Dendritic Cell Maturation and Antigen Presentation through Regulation of Tumor Necrosis Factor Alpha Secretion Infect. Immun., October 1, 2007; 75(10): 4980 - 4989. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Jimenez de Bagues, S. Loisel-Meyer, J.-P. Liautard, and V. Jubier-Maurin Different Roles of the Two High-Oxygen-Affinity Terminal Oxidases of Brucella suis: Cytochrome c Oxidase, but Not Ubiquinol Oxidase, Is Required for Persistence in Mice Infect. Immun., January 1, 2007; 75(1): 531 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Agarwal, T. R. Raghunand, and W. R. Bishai Regulation of the expression of whiB1 in Mycobacterium tuberculosis: role of cAMP receptor protein. Microbiology, September 1, 2006; 152(Pt 9): 2749 - 2756. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kalamidas, M. P. Kuehnel, P. Peyron, V. Rybin, S. Rauch, O. B. Kotoulas, M. Houslay, B. A. Hemmings, M. G. Gutierrez, E. Anes, et al. cAMP synthesis and degradation by phagosomes regulate actin assembly and fusion events: consequences for mycobacteria. J. Cell Sci., September 1, 2006; 119(Pt 17): 3686 - 3694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Loisel-Meyer, M. P. Jimenez de Bagues, E. Basseres, J. Dornand, S. Kohler, J.-P. Liautard, and V. Jubier-Maurin Requirement of norD for Brucella suis Virulence in a Murine Model of In Vitro and In Vivo Infection Infect. Immun., March 1, 2006; 74(3): 1973 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bai, L. A. McCue, and K. A. McDonough Characterization of Mycobacterium tuberculosis Rv3676 (CRPMt), a Cyclic AMP Receptor Protein-Like DNA Binding Protein J. Bacteriol., November 15, 2005; 187(22): 7795 - 7804. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhao, Z. He, N. Chen, Y.-Y. Cho, F. Zhu, C. Lu, W.-y. Ma, A. M. Bode, and Z. Dong 2-Arachidonoylglycerol Stimulates Activator Protein-1-dependent Transcriptional Activity and Enhances Epidermal Growth Factor-induced Cell Transformation in JB6 P+ Cells J. Biol. Chem., July 22, 2005; 280(29): 26735 - 26742. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Ha, R. Waterhouse, J. Wessells, J. A. Wu, and G. S. Dveksler Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE2, and TGF-{beta}1 J. Leukoc. Biol., June 1, 2005; 77(6): 948 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Gazdik and K. A. McDonough Identification of Cyclic AMP-Regulated Genes in Mycobacterium tuberculosis Complex Bacteria under Low-Oxygen Conditions J. Bacteriol., April 15, 2005; 187(8): 2681 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Aronoff, C. Canetti, C. H. Serezani, M. Luo, and M. Peters-Golden Cutting Edge: Macrophage Inhibition by Cyclic AMP (cAMP): Differential Roles of Protein Kinase A and Exchange Protein Directly Activated by cAMP-1 J. Immunol., January 15, 2005; 174(2): 595 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yadav, S. K. Roach, and J. S. Schorey Increased Mitogen-Activated Protein Kinase Activity and TNF-{alpha} Production Associated with Mycobacterium smegmatis- but Not Mycobacterium avium-Infected Macrophages Requires Prolonged Stimulation of the Calmodulin/Calmodulin Kinase and Cyclic AMP/Protein Kinase A Pathways J. Immunol., May 1, 2004; 172(9): 5588 - 5597. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |